PACS Stock Analysis: Buy, Sell, or Hold?
PACS - PACS Group, Inc.
$46.01
-0.98 (-2.09%)
▼
5d:
-1.79%
30d:
+3.81%
90d:
+37.14%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 04, 2026
TODAY
Smart Money Accumulation
None View Scanner →
Strength: 4.9/10
Get Alerted When PACS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PACS shows positive signals but monitor for confirmation. Market pricing in 4.1% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: PACS shows positive signals but monitor for confirmation. Market pricing in 4.1% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$51.28
Based on 4.7% avg growth
INTRINSIC VALUE TODAY
$31.84
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PACS is currently trading at $46.01, which is considered slightly high relative to its 30-day fair value range of $42.27 to $46.47. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.8) compared to its historical average (16.7). At these levels, the market is pricing in 4.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PACS is in a strong uptrend. Immediate support is located at $43.94, while resistance sits at $48.00.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $52.67 (+14.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PACS is in a strong uptrend. Immediate support is located at $43.94, while resistance sits at $48.00.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $52.67 (+14.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$42.27 -
$46.47
Company Quality Score
54/100
(HOLD)
Options IV Signal
44th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
65.0%
All Signals
- NEUTRAL: Options fairly priced (IV 44th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($52.67)
- NEUTRAL: Market pricing in 4.1% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$42.27 -
$46.47
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$5.24
(11.4%)
Support & Resistance Levels
Support Level
$43.94
Resistance Level
$48.00
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.80
Wall Street Target
$52.67
(+14.5%)
Revenue Growth (YoY)
11.2%
Earnings Growth (YoY)
194.1%
Profit Margin
4.5%
Valuation Premium vs History
+4.1% premium
PE vs Historical
18.8 vs 16.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.1%
(market-implied from PE analysis)
1-Year Target
$47.90
(+4%)
2-Year Target
$49.86
(+8%)
3-Year Target
$51.90
(+13%)
3-Yr Target (if PE normalizes)
(PE: 19→17)
PE COMPRESSION
$46.09
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 5.3%)
$59.24
(+29%)
Base:
(SPY PE: 18.8, Growth: 5.3%)
$53.74
(+17%)
Bear:
(PE: 16.0, Growth: 5.3%)
$45.68
(-1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 29.93 | Current EPS (TTM): $1.57
Bull Case
$80.55
(+75%)
Analyst growth 55.8%, PE expands to 32.9
Base Case
$73.23
(+59%)
Market implied 55.8%, PE stable at 29.9
Bear Case
$31.95
(-31%)
Severe decline -20.0%, PE contracts to 25.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 7:26 PM ET
Data refreshes hourly during market hours. Next update: 8:26 PM
Data refreshes hourly during market hours. Next update: 8:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PACS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua Jergensen
SELL
36335 shares
2026-03-13
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$277 | 52 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 46 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 61 BUY |
Advanced PACS Option Strategies
Professional options setups generated by AI based on today's PACS price and gamma walls.
